Capital

302, 2022

Avicanna Provides Q4-2021 Results Fiscal 2022 Outlook

TORONTO - Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based, ...

2101, 2022

Numinus Wellness Inc. Reports Q1 2022 Results

VANCOUVER, BC - Numinus Wellness Inc. (TSX: NUMI) (OTC: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced its ...

Go to Top